Establishment Labs Holdings (ESTA) Income towards Parent Company (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Income towards Parent Company of -$13.4 million for Q1 2026, up 35.38% year-over-year from -$9.9 million in Q1 2025, and down 411.74% quarter-over-quarter from -$2.6 million in Q4 2025.
Establishment Labs Holdings (ESTA) Income towards Parent Company (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Income towards Parent Company history runs 10 years deep, the most recent figure standing at -$13.4 million for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 35.38% year-over-year to -$13.4 million; the TTM figure through Mar 2026 stood at -$43.7 million (up 50.92% YoY), while the FY2025 annual figure was -$51.1 million, up 39.64% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$13.4 million, down from -$2.6 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$2.6 million in Q4 2025, with the low at -$37.1 million in Q2 2022.
- The 5-year median for Income towards Parent Company is -$16.7 million (2024), against an average of -$17.8 million.
- The sharpest annual moves came in 2022 and 2025: Income towards Parent Company plunged 597.22% in 2022, then soared 92.43% in 2025.
- Establishment Labs Holdings' Income towards Parent Company stood at -$13.6 million in 2022, then sank by 51.47% to -$20.5 million in 2023, then slumped by 68.1% to -$34.5 million in 2024, then jumped by 92.43% to -$2.6 million in 2025, then plunged by 411.74% to -$13.4 million in 2026.
- Business Quant data shows ESTA's Income towards Parent Company at -$13.4 million in Q1 2026, -$2.6 million in Q4 2025, and -$11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Establishment Labs Holdings | 2.18 Bn | 2.11 Bn | 47.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.75 Mn |
| Mar 31, 2026 | -13.38 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Sep 30, 2025 | -11.15 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | -34.53 Mn |
| Sep 30, 2024 | -16.68 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Mar 31, 2024 | -16.20 Mn |
| Dec 31, 2023 | -20.54 Mn |
| Sep 30, 2023 | -29.27 Mn |
| Jun 30, 2023 | -16.75 Mn |
| Mar 31, 2023 | -11.94 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -18.61 Mn |
| Jun 30, 2022 | -37.11 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -14.19 Mn |
| Sep 30, 2021 | -14.68 Mn |